Nordic Liposomes ApS: Financial statements 2024
CVR: 43161725
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Nordic Liposomes ApS (CVR 43161725) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 100,194 and a net result of DKK 66,871 compared with DKK 67,655 the year before. That is a decrease of 3.8% compared with the year before. Equity in the 2024 report amounted to DKK 106,746. The solvency ratio was 19.2%.
- Gross Profit
- DKK 100,194
- Profit/Loss
- DKK 66,871
- Equity
- DKK 106,746
- Total Assets
- DKK 556,295
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Nordic Liposomes ApS has published its annual report for 2023. Gross profit came to DKK 104,123, and the net result was DKK 67,655.
About Nordic Liposomes ApS
Nordic Liposomes ApS is a Danish company of the type Anpartsselskab based in Søndersø, founded in 2022. The company is registered under the industry Andre fremstillingsaktiviteter i.a.n.. The company was previously named Nordicliposomes ApS. The management consists of Morten Thvilum and Trine Albers Huusfeldt. The company is owned by CIRRUS HOLDING ApS and Huusfeldt ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 546,069 and a net result of DKK 336,862 compared with DKK 66,871 the year before. Equity in the 2025 report amounted to DKK 443,608.
